此网站需要运行 JavaScript!

    Protein and antibody
    • Our protein and antibody related products and services primarily include the production, detection and analysis of polypeptide, proteins and antibodies. Our protein related products include polypeptide, protein extraction, and analysis kits. Our protein related services include protein detection, analysis, expression and purification. Our antibody related products include the production of antibodies (including polyclonal and monoclonal antibodies) and immunology-related products and antibody related kits. Our antibody services include customised antibody production and immunology experiments.
    Protein Expression Technology
    Protein expression technology is also called recombinant or fusion protein technology, which refers to a process to obtain target protein by ways of genetic engineering. There are two primary aspects of recombinant protein expression technology, namely, the expression of the target protein and the purification of the target protein. There are various expression systems for the expression of recombinant proteins, the basic technology of all of which are relatively mature. We possess a mature protein expression platform, including prokaryotic expression and yeast expression systems, and downstream recombinant protein purification technology. In terms of protein purification, we adopt mainstream chromatography technology in protein purification. We also provide a series of protein related services such as 2D electrophoresis and amino acid sequencing.
    Antibodies
    Antibodies are proteins produced by living organisms in response to exogenous substances, and can specifically identify the exogenous substances. Owing to their special properties, antibodies are widely used. Antibody preparation is the process in which specific antibodies are obtained by immunising animals with designed antigens.
    We started to build antibody preparation platform in 2011 and we currently have production and testing platforms for polyclonal antibodies and monoclonal antibodies. As at 30 June 2017, we carried over 12,000 types of antibodies. Based on our current production platform, we have developed antibody services including production of antibodies and related immunology experiments.